Regulatory Advisory Programs
Retained FDA strategy and execution for medtech, AI/SaMD, OTC drugs, and cosmetics. Built to reduce compliance risk, accelerate submissions, strengthen reimbursement readiness, and keep you inspection-ready.
Programs
For OTC brands, cosmetic companies, small device firms.
- Quarterly label review updates
- Annual establishment registration reminders
- SPL/NDC monitoring
- MoCRA updates
- One compliance call per month
- Email access (48-hour response)
This is your “sleep at night” package.
For funded medtech or AI device startups.
- Ongoing 510(k) support
- Predicate watch alerts
- Regulatory strategy calls (2/month)
- Software change control advisory
- QMS light oversight
- Commercialization strategy check-ins
- Investor-ready regulatory summaries
Aligns with VC-facing positioning and fast-moving development cycles.
For revenue-stage device companies.
- Ongoing ISO 14971 review
- IEC 62304 oversight
- Cybersecurity monitoring
- Mock inspection quarterly
- CAPA review
- Labeling change impact analysis
- Direct FDA communication support
This is your fractional VP of Regulatory model.
Recurring revenue through recurring compliance.
- IRS 213(d) review updates
- Truemed-style documentation support
- NDC alignment review
- Insurance strategy roadmap updates
- Quarterly reimbursement eligibility refresh
- ICD-10 alignment review
Positioned for brands scaling through FSA/HSA and broader reimbursement pathways.
AI Device Compliance Network.
- Monthly AI regulatory brief
- FDA enforcement updates
- AI policy change alerts
- Cybersecurity SBOM updates
- Closed-door strategy call (group format)
Scales efficiently with high margin and consistent demand.
Pipeline subscription for predictable runway.
- Predicate search
- Testing plan development
- Risk file drafting
- eSTAR build in phases
- Submission prep
This smooths cash flow and makes the “yes” easier.
Cosmetic Compliance Shield.
- Ingredient watch
- Claims review
- Amazon compliance support
- Retail readiness checklist
- Ad claim monitoring
- Adverse event SOP oversight
Built for MoCRA, claims discipline, and retail pressure.
FDA Strategy for Fundraising.
- Regulatory roadmap deck updates
- 510(k) probability analysis
- Clinical necessity memo
- Due diligence support calls
- Investor Q&A prep
Structured narratives investors expect in diligence.
FDA Access Pass.
- 2 quick calls/month
- Email support
- Basic compliance questions
- Claim reviews
High-volume, low-lift membership option with clear boundaries.
How it works
Ready to start?
Current advisory capacity is limited. Applications are reviewed within 48 hours for mutual fit.
